Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC14B | O60729 | 2/20 | 0.34 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CTRC | Q99895 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | PLEC | Q15149 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8081468 | 0.81 | CDC14B (0.33) | CDC14BCDC14AMAOBKMT2AALDH1A1 | |
| SCHEMBL7857381 | 0.75 | KMT2A (0.33) | MAOBPOLBCTRCKMT2AMEN1 | |
| SCHEMBL3371626 | 0.69 | ALDH1A1 (0.45) | POLBKMT2AMEN1USP2ALDH1A1 | |
| Phosphoric Acid SCHEMBL27982532 | 0.69 | HDAC4 (0.45) | ALDH1A1GPR84 | |
| Phosphoric Acid SCHEMBL242261 | 0.64 | HNF4A (0.48) | ALDH1A1GPR84 | |
| Phosphoric Acid SCHEMBL28476358 | 0.62 | BACE1 (0.45) | KMT2AMEN1ALDH1A1GPR84 | |
| SCHEMBL608536 | 0.60 | ALDH1A1 (0.50) | CTRCALDH1A1 | |
| SCHEMBL3360427 | 0.60 | KDM4E (0.40) | CDC14BCDC14APOLBKDM4EALDH1A1 | |
| Phosphoric Acid SCHEMBL28543871 | 0.60 | TDP2 (0.42) | ALDH1A1GPR84 | |
| Phosphoric Acid SCHEMBL641209 | 0.60 | WDR5 (0.46) | KDM4EKMT2AMEN1ALDH1A1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8053151-B2 | Phosphonate containing photoconductors | XEROX CORPORATION (US) | 2011-11-08 | — | — | US | claimed |
| US-20090297967-A1 | PHOSPHONATE HOLE BLOCKING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-12-03 | — | — | US | claimed |
| US-5834581-A | Process for making polyimide-polyamic ester copolymers | OLIN MICROELECTRONIC CHEMICALS, INC. (US) | 1998-11-10 | — | — | US | claimed |
| EP-4600355-A1 | NUCLEIC ACID EXTRACTION METHOD, NUCLEIC ACID AMPLIFICATION METHOD, NUCLEIC ACID EXTRACTION KIT, AND PCR TEST KIT | National Institute for Materials Science (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20240045329-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, ELECTRONIC COMPONENT, ANTENNA ELEMENT, SEMICONDUCTOR PACKAGE, AND COMPOUND | TORAY INDUSTRIES, INC. (JP) | 2024-02-08 | — | — | US | disclosed |
| US-10023530-B2 | Diamine, polyamic acid, and polyimide | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-07-17 | — | — | US | disclosed |
| US-9976086-B2 | Liquid crystal aligning agent containing polyimide precursor having thermally-leaving group and/or polyimide | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20160264520-A1 | NOVEL DIAMINE, POLYAMIC ACID, AND POLYIMIDE | NISSAN CHEMICAL INDUSTRIES. LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160264867-A1 | LIQUID CRYSTAL ALIGNING AGENT CONTAINING POLYIMIDE PRECURSOR HAVING THERMALLY-LEAVING GROUP AND/OR POLYIMIDE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| US-9284393-B2 | Biomolecule-compatible, highly branched polymer and biomolecular-recognition surface | KYUSHU UNIVERSITY (JP) | 2016-03-15 | — | — | US | disclosed |
| US-8062816-B2 | Phosphonate hole blocking layer photoconductors | XEROX CORPORATION (US) | 2011-11-22 | — | — | US | disclosed |
| US-20090297967-A1 | PHOSPHONATE HOLE BLOCKING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-12-03 | — | — | US | disclosed |
| US-5834581-A | Process for making polyimide-polyamic ester copolymers | OLIN MICROELECTRONIC CHEMICALS, INC. (US) | 1998-11-10 | — | — | US | disclosed |
| US-5789525-A | Process for making polyimides from diamines and tetracarboxylic diacid diester | OLIN MICROELECTRONIC CHEMICALS, INC. (US) | 1998-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023530-B2 | Diamine, polyamic acid, and polyimide | H1-2, H1-4, H1-0 | CDC14B 3061/4885CDC14A 3022/4885MAOB 622/4885 |
| US-20160264520-A1 | NOVEL DIAMINE, POLYAMIC ACID, AND POLYIMIDE | H1-4, H1-2, H1-5 | CDC14B 2945/4885CDC14A 3039/4885MAOB 655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.